AnalystsEric SchmidtEric Schmidt's Stock Forecasts
AnalystsEric Schmidt
Sectors:
Industries:
Analyst Ranking
Top 31%
#1419 out of 4572 analysts
Average Return
+22.4%
Win Rate
57%4 out of 7
Risk vs Reward
Poor
Good
Eric Schmidt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
G1 Therapeutics IncGTHX | +129.24% | $17.99 | $41.24 | 2017-06-11 - 2018-06-12 | Buy |
Bioverativ IncBIVV | +68.97% | $62.13 | $104.98 | 2017-07-09 - 2018-03-08 | Buy |
Vertex Pharmaceuticals IncVRTX | +7.67% | $373.50 | $402.14 | 2023-10-16 - 2024-05-01 | Strong Buy |
Avidity Biosciences IncRNA | +7.63% | $23.97 | $25.80 | 2024-03-13 - 2024-05-01 | Strong Buy |
Eric Schmidt Analyst Color
Get additional color on Eric Schmidt's coverage of popular stocks
Eric Schmidt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avidity Biosciences IncRNA | 1 | Strong Buy | $60.00 | +132.56% | Initiates Coverage On | 2 months ago |
Biogen IncBIIB | 2 | Strong Buy | $311.00 | +43.89% | Reiterates | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Strong Buy | $370.00 | -7.99% | Reiterates | 7 months ago |
Bioverativ IncBIVV | 1 | Buy | N/A | N/A | Upgrades | 7 years ago |
G1 Therapeutics IncGTHX | 1 | Buy | $31.00 | N/A | Initiates Coverage On | 7 years ago |
Ovid Therapeutics IncOVID | 1 | Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.